Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman has maintained an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) and increased the price target from $36 to $37.
January 16, 2024 | 5:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper and raises the price target from $36 to $37.
The increase in price target by Barclays reflects a positive outlook on Keurig Dr Pepper's stock, which could lead to increased investor confidence and potentially a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100